Navigation Links
UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
Date:9/1/2011

ANAHEIM, Calif., Sept. 1, 2011 /PRNewswire/ -- Please replace the release dated August 24, 2011 with the following updated version.  First graph, second and third sentences added and should read: The Company will provide attendees an updated investor presentation, which will be filed in a Form 8K with the SEC after the close of the U.S. financial markets on Friday, September 9, 2011.  This presentation will also be available at http://ir.questcor.com/sec.cfm.  Second graph, second and third sentences updated and should read: Don M. Bailey, President and Chief Executive Officer, and members of the executive management team are scheduled to provide an overview of the Company in an "unplugged" fireside chat and Q&A session on Wednesday, September 14, 2011 at 8:00 a.m. ET.  A live audio only webcast and subsequent archived replay of the discussion will be accessible at http://ir.questcor.com/events.cfm.

The full updated release reads:

Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September

Questcor Pharmaceuticals, Inc. (NASDAQ:  QCOR) announced today that members of its executive management team will present at the following investor conferences in early September.  The Company will provide attendees an updated investor presentation, which will be filed in a Form 8K with the SEC after the close of the U.S. financial markets on Friday, September 9, 2011.  This presentation will also be available at http://ir.questcor.com/sec.cfm.

  • The Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York City.  Don M. Bailey, President and Chief Executive Officer, and members of the executive management team are scheduled to provide an overview of the Company in an "unplugged" fireside chat and Q&A session on Wednesday, September 14, 2011 at 8:00 a.m. ET.  A live audio only webcast and subsequent archived replay of the discussion will be accessible at http://ir.questcor.com/events.cfm.
  • UBS Global Life Sciences Conference at the Grand Hyatt in New York City.  Mr. Bailey is scheduled to present on Monday, September 19, 2011 at 10:30 a.m. ET.  A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm.

About Questcor

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of acute exacerbations of multiple sclerosis in adults, the treatment of nephrotic syndrome, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus."  Questcor is also exploring the use of Acthar to treat systemic lupus erythematosus, for which Acthar is approved as both a maintenance therapy and to treat exacerbations.  Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need.  For more information, please visit www.questcor.com.


'/>"/>
SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
2. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
3. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
4. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
5. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
6. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
7. Questcor Pharmaceuticals to Present at the Needham Healthcare Conference
8. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
9. Questcor Pharmaceuticals Selects BDO USA as its Auditor
10. Questcor Reports 2010 Financial Results
11. Questcor to Report Fourth Quarter and Full Year 2010 Earnings and Conduct Conference Call on February 23, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Laboratories, Inc. (NASDAQ: IPXL ) today announced that it plans ... Raymond James and Associates, 38 th Annual Institutional Investors ... Orlando, FL. Cowen and Company 37 th ... 2017 in Boston, MA. Barclays ... Miami, FL. Individuals may listen ...
(Date:2/27/2017)... PETACH TIKVAH, Israel , Feb. 27, ... a leading developer of adult stem cell technologies for ... S. Almenoff , M.D., Ph.D., FACP, and Arturo ... Directors.  "Dr. Almenoff and Mr. Araya ... at an exciting time for our company," said ...
(Date:2/24/2017)... Research and Markets has announced the addition of the ... to 2025" report to their offering. ... The Global Wireless Health Market is ... next decade to reach approximately $330.5 billion by 2025. ... the given segments on global as well as regional levels presented ...
Breaking Medicine Technology:
(Date:2/26/2017)... VA (PRWEB) , ... February 26, 2017 , ... ODH, ... Managed Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ... with PerformCARE to use behavioral health analytics to improve Medicaid population health management. , ...
(Date:2/25/2017)... ... , ... FCPX users now have the ability to sharpen a desired color ... users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical sharpening, ... users can visually see the color range effected with ease all within Final ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after ... Travel Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run ... 420-page book measures almost a metre across when open, weighs in at more than ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald E. ... announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as ... beginning April 10. Dr. Bell comes to Liberty from the Ohio University Heritage ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... and hearing disabilities, it is so critically important that we all are aware ... That is why Mediaplanet is proud to announce the launch of its newest ...
Breaking Medicine News(10 mins):